Genotypic Tumor Progression Classifier and Predictor
Actively dividing tumors appear to progress to a life threatening condition more rapidly than slowly dividing tumors. Assessing actively dividing tumors currently involves a manual assessment of the number of mitotic cells in a histological slide prepared from the tumor and assessed by a trained pathologist. Disclosed is a method for using cumulative information from a series of expressed genes to determine tumor prognosis. This cumulative information can be used to categorize tumor samples into high mitotic states or low mitotic states using a mathematical algorithm and gene expression data derived from microarrays or quantitative-Polymerase Chain Reaction (Q-PCR) data. The specific mathematical description outlines how the algorithm assesses the most informative subset of genes from the full list of genes during the assessment of each sample.
Patents:US 20,100,240,540
Inventor(s):
YEATMAN TIMOTHY [US]; ENKEMANN STEVEN ALAN [US]; ESCHRICH STEVEN [US]
Type of Offer:
Licensing
« More Diagnostic Patents